Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
|Articles|June 22, 2022
How to Choose a Third-Party Logistics
Author(s)Knipper
When choosing a 3PL whether for a new product launch in the near future or re re-evaluating your current situation, certain key considerations must be addressed before you make a final decision.
Advertisement
Advertisement
Related to this article
An FTC settlement moved one PBM aggregator onshore, but manufacturers still lack contract-level clarity on what affiliated fees actually buy.
Simvera PSP applies queueing science so manufacturers can test the cost and patient impact of hub staffing decisions before locking them in.
Gregg Gorniak explains how AI, RFID and serialized data are helping trading partners move DSCSA compliance from a regulatory checkbox to a source of shared operational value.
As HRSA's 340B Rebate Model Pilot moves toward its effective date, Valerie Bandy, PharmD, of Tecsys explains what drug-by-drug rebate tracking really demands from hospital and health system pharmacies.
Pharma pricing shifts beyond PBM rebates as Medicare and cash channels reshape launches, WAC cuts and access strategies.
In the final installment of his interview with Pharmaceutical Commerce, Cencora's Ameer Ali outlines how supply chain stakeholders should prepare systems, processes and trading partners for the shift to NDC-12.
In the final installment of his interview with Pharmaceutical Commerce, Cencora's Gregg Gorniak looks back at DSCSA's five-year evolution and where serialized data is creating value beyond compliance.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The PBM Entity No Pharmaceutical Company Directly Contracted With
2
What 340B Rebate Tracking Really Demands From Pharmacies
3
Pharma Pulse: Behind the Scenes of LogiPharma USA 2026
4
The Great Repricing: Seven Assumptions That No Longer Hold
5